Literature DB >> 17129856

Establishing a workplace antiretroviral therapy programme in South Africa.

S Charalambous1, A D Grant, J H Day, L Pemba, R E Chaisson, P Kruger, D Martin, R Wood, B Brink, G J Churchyard.   

Abstract

Ways to expand access to antiretroviral treatment (ART) in low income settings are being sought. We describe an HIV care programme including ART in an industrial setting in South Africa. The programme uses guidelines derived from local and international best practice. The training component aims to build capacity among health care staff. Nurses and doctors are supported by experienced HIV clinicians through telephone consultation and site visits. Patients undergo a three-stage counselling procedure prior to starting ART. Drug regimens and monitoring are standardised and prophylaxis against opportunistic infections (isoniazid and cotrimoxazole) is offered routinely. Laboratory and pharmacy services, using named-patient dispensing, are centralized. The programme is designed to ensure that data on clinical and economic outcomes will be available for programme evaluation. Between November 2002-December 2004, ART delivery has been established at 70 ART workplace ART sites. The sites range from 200 to 12000 employees, and from small occupational health clinics and general practitioner rooms to larger hospital clinics. During this period, 2456 patients began ART. Of those on treatment for at least three months, 1728 (78%) have been retained on the programme and only 38 (1.7%) patients have failed the first-line ART regimen. This model for delivery of ART is feasible and successful in an industrial setting. The model may be generalizable to other employment health services in settings of high HIV prevalence, and as a model for implementing ART in other types of health-care settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17129856     DOI: 10.1080/09500340600677872

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  20 in total

1.  Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.

Authors:  Salome Charalambous; Alison D Grant; Craig Innes; Christopher J Hoffmann; Rob Dowdeswell; Jan Pienaar; Katherine L Fielding; Gavin J Churchyard
Journal:  AIDS       Date:  2010-11       Impact factor: 4.177

2.  Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.

Authors:  Christopher J Hoffmann; Katherine L Fielding; Salome Charalambous; Mark S Sulkowski; Craig Innes; Chloe L Thio; Richard E Chaisson; Gavin J Churchyard; Alison D Grant
Journal:  AIDS       Date:  2008-01-02       Impact factor: 4.177

3.  Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa.

Authors:  Liesl S Page-Shipp; Salome Charalambous; Surita Roux; Belinda Dias; Clement Sefuti; Gavin J Churchyard; Alison D Grant
Journal:  Sex Transm Infect       Date:  2007-06-13       Impact factor: 3.519

4.  Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa.

Authors:  Ziad El-Khatib; Allison K Delong; David Katzenstein; Anna Mia Ekstrom; Johanna Ledwaba; Lerato Mohapi; Fatima Laher; Max Petzold; Lynn Morris; Rami Kantor
Journal:  J AIDS Clin Res       Date:  2011-02-18

5.  A systematic review of best practices in HIV care.

Authors:  Geoffrey Maina; Judy Mill; Jean Chaw-Kant; Vera Caine
Journal:  J HIV AIDS Soc Serv       Date:  2016-03-22

6.  Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial.

Authors:  Ian Sanne; Catherine Orrell; Matthew P Fox; Francesca Conradie; Prudence Ive; Jennifer Zeinecker; Morna Cornell; Christie Heiberg; Charlotte Ingram; Ravindre Panchia; Mohammed Rassool; René Gonin; Wendy Stevens; Handré Truter; Marjorie Dehlinger; Charles van der Horst; James McIntyre; Robin Wood
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

7.  Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study.

Authors:  Elizabeth C Russell; Salome Charalambous; Lindiwe Pemba; Gavin J Churchyard; Alison D Grant; Katherine Fielding
Journal:  BMC Public Health       Date:  2010-07-23       Impact factor: 3.295

8.  Private sector provision and financing of AIDS treatment in Africa: current developments.

Authors:  Frank Feeley; Patrick Connelly; Sydney Rosen
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

9.  Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.

Authors:  Christopher J Hoffmann; Johanna Ledwaba; Jin-Fen Li; Victoria Johnston; Gillian Hunt; Katherine L Fielding; Richard E Chaisson; Gavin J Churchyard; Alison D Grant; Jeffrey A Johnson; Salome Charalambous; Lynn Morris
Journal:  Antivir Ther       Date:  2013-06-10

10.  Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.

Authors:  Christopher J Hoffmann; Salome Charalambous; John Sim; Joanna Ledwaba; Graham Schwikkard; Richard E Chaisson; Katherine L Fielding; Gavin J Churchyard; Lynn Morris; Alison D Grant
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.